CRISPR Therapeutics AG (CRSP) EBT (2015 - 2026)
CRISPR Therapeutics AG (CRSP) reported EBT of -$122.1 million for Q1 2026, up 9.49% on a YoY basis from -$111.5 million in Q1 2025, and up 24.88% sequentially from -$162.5 million in Q4 2025.
CRISPR Therapeutics AG (CRSP) EBT (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 12 years of EBT data on file, last reported at -$122.1 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 9.49% year-over-year to -$122.1 million; the trailing twelve-month figure through Mar 2026 stood at -$597.7 million (down 2790.87% YoY), and the FY2025 full-year result was -$610.5 million, down 1580.63% from the prior year.
- EBT improved to -$122.1 million in Q1 2026, from -$162.5 million in the prior quarter.
- In the past five years, EBT ranged from a high of $367.3 million in Q4 2024 to a low of -$207.3 million in Q2 2025.
- A 5-year average of -$87.8 million and a median of -$120.1 million in 2022 frame the typical range for EBT.
- Across the five-year window, EBT soared 310.01% in 2024 and plunged 144.25% in 2025, its largest moves.
- Tracing CRSP's EBT over 5 years: stood at -$120.1 million in 2022, then surged by 174.62% to $89.6 million in 2023, then soared by 310.01% to $367.3 million in 2024, then sank by 144.25% to -$162.5 million in 2025, then grew by 24.88% to -$122.1 million in 2026.
- Business Quant data shows CRSP's EBT at -$122.1 million in Q1 2026, -$162.5 million in Q4 2025, and -$105.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | -122.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.09 Mn |
| Dec 31, 2025 | -162.53 Mn |
| Sep 30, 2025 | -105.82 Mn |
| Jun 30, 2025 | -207.26 Mn |
| Mar 31, 2025 | -134.89 Mn |
| Dec 31, 2024 | 367.29 Mn |
| Sep 30, 2024 | -85.07 Mn |
| Jun 30, 2024 | -125.12 Mn |
| Mar 31, 2024 | -115.87 Mn |
| Dec 31, 2023 | 89.58 Mn |
| Sep 30, 2023 | -111.74 Mn |
| Jun 30, 2023 | -76.82 Mn |
| Mar 31, 2023 | -51.75 Mn |
| Dec 31, 2022 | -120.05 Mn |
| Sep 30, 2022 | -175.12 Mn |
| Jun 30, 2022 | -179.72 Mn |
| Mar 31, 2022 | -175.61 Mn |
| Dec 31, 2021 | -143.50 Mn |
| Sep 30, 2021 | -127.75 Mn |
| Jun 30, 2021 | 763.37 Mn |